OTC Markets · Medical Devices · USD

STRATA Skin Sciences, Inc. (SSKN) Stock Analysis

STRATA Skin Sciences, Inc. (SSKN) is a Medical Devices stock listed on OTC Markets and quoted in US Dollar.

Last Updated: October 20, 2026

SSKN

$0.0002

$0.00 (0.00%)

Oct 20, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare SSKN with… →

SSKN Key Statistics

As of Oct 20, 2026

Trading

Open: $0.0002
Previous Close: $0.0002
Beta: 0.21

Valuation

Market Cap: $1.18K
P/E Ratio: unprofitable
PEG Ratio: 0.03
EPS (ttm): −270.00

Financials (FY)

Revenue (FY): $30.70M−8.54%
Net Income (FY): −$6.26M
Profit margin: −20.40%
Shares Outstanding: 5.89M
1-Year Return: −99.99%

Dividend and dates

Avg Volume: 3.62K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 20, 2026, SSKN closed at $0.0002, −99.99% over 1 year.

STRATA Skin Sciences, Inc. (SSKN) has a market capitalization of $1.18K.

In fiscal 2025, SSKN reported revenue of $30.70M.

SSKN Stock Return by Calendar Year

STRATA Skin Sciences, Inc. (SSKN) 10-year return: what $10,000 became

1 year: $10,000 $1; −99.99%
5 years: $10,000 $1; −99.99%
10 years: $10,000 $0.78; −99.99%

If you had invested $10,000 in STRATA Skin Sciences, Inc. (SSKN) 10 years ago, at the close on October 20, 2016, it would have been worth $0.78 at the close on October 20, 2026: −99.99% in total, −61.14% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

+428.99%−99.98%

2016*2017201820192020202120222023202420252026*

Year	Return
2026 (partial year)	−99.98%
2025	−56.70%
2024	+428.99%
2023	−30.38%
2022	−46.07%
2021	−2.33%
2020	−27.88%
2019	−20.00%
2018	+111.38%
2017	−44.09%
2016 (partial year)	−31.27%

As of October 20, 2026.

SSKN Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$30.70M	−$6.26M	−20.4%
2024	$33.56M	−$10.09M	−30.1%
2023	$33.36M	−$10.83M	−32.5%
2022	$36.16M	−$5.55M	−15.3%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$30.70M	$17.88M	−$5.84M	−$6.26M	−20.4%
2024	$33.56M	$19.22M	−$4.99M	−$10.09M	−30.1%
2023	$33.36M	$18.46M	−$6.32M	−$10.83M	−32.5%
2022	$36.16M	$21.77M	−$4.65M	−$5.55M	−15.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

SSKN Valuation vs Medical Devices Median

Median of 145 stocks

Metric	SSKN	Medical Devices median	vs median
P/S ratio	0.00	2.53	0.0x the median
Profit margin	−20.40%	−14.78%	5.6 pts below

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Analysis

Data-derived

Company Overview

STRATA Skin Sciences, Inc. (SSKN) carries a market capitalisation of $1.18K. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 114 employees.

The most recent close on file for SSKN is $0.0002, dated October 20, 2026. The close was unchanged from the previous session.

Financial Health

In fiscal 2025, STRATA Skin Sciences, Inc. reported revenue of $30.70M. Against the prior fiscal year total of $33.56M, that is a change of −8.54%. The same year closed with a net loss of $6.26M. Profit margin runs at −20.4%. That is 5.6 percentage points below the Medical Devices median of −14.78%. Trailing earnings per share are −270.

Across the 4 fiscal years on file, revenue moves from $36.16M in 2022 to $30.70M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.03.

The trailing one-year total return is −99.99%. Measured over 10 years, that is −61.14% a year compounded. Beta against the wider market is reported at 0.21. Annualized volatility over the trailing 10 years is 1,789.94%.

Growth & Income

The record shows no dividend for SSKN.

Across the complete calendar years on file, 2024 returned +428.99% and 2025 returned −56.70%. Of the 9 complete calendar years on file, 2 finished higher. 2026 is still running; the total return is −99.98% year to date.

Peer Comparison

STRATA Skin Sciences, Inc. (SSKN) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
STRATA Skin Sciences, Inc.	SSKN	$1.18K	—
Abbott Laboratories	ABT	$173.92B	32.4
Medtronic plc.	MDT	$119.00B	22.9
Stryker Corporation	SYK	$114.15B	30.8

The Medical Devices industry average P/E ratio is 27.1x. STRATA Skin Sciences, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 20, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

MDT

Medtronic plc.

$119.00B

SYK

Stryker Corporation

$114.15B

BSX

Boston Scientific Corporation

$64.33B

Edwards Lifesciences Corporation

$50.95B

GEHC

GE HealthCare Technologies Inc.

$31.17B

View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

JNJ

Johnson & Johnson

$621.22B

ABBV

AbbVie Inc.

$503.27B

UNH

UnitedHealth Group Incorporated

$374.30B

MRK

Merck & Co., Inc.

$369.78B

View all Healthcare stocks →

About STRATA Skin Sciences, Inc.

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through Dermatology Recurring Procedures and Dermatology Procedures Equipment segments. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc. and changed its name to STRATA Skin Sciences, Inc. in December 2015. STRATA Skin Sciences, Inc. was incorporated in 1989 and is headquartered in Horsham, Pennsylvania.

Visit website →